Skip to main content
    B

    Briacell Therapeutics Corp (BCTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.30
    -0.09 (-2.65%)

    Market Cap: $29.60M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Briacell Therapeutics Corp (BCTX) Earnings: Report Dates and Results

    Updated Oct 28, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Briacell Therapeutics (BCTX) is expected to report earnings on Dec 10, 2026. In the quarter ended Jul 31, 2026, Briacell Therapeutics reported EPS of -$1.24. It beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    53%(8/15)
    Avg Surprise
    -6.28%
    Streak
    2 Q

    Next Report

    BCTX has an expected report date of Dec 10, 2026.

    Earnings History

    Of the 15 quarters below that had an estimate, BCTX beat 8 and missed 7. The widest gap in the table came in the quarter ended Oct 31, 2023, when EPS landed 300.00% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Jul 31, 2026-$1.24N/AN/AN/AN/A-3200.0%N/AN/AOct 28, 2026
    Apr 30, 2026-$0.99N/AN/AN/AN/AN/AN/AN/AJun 9, 2026
    Jan 31, 2026-$2.58-$4.84-$4.84 - -$4.84N/AN/AN/A10 up, 0 downMar 10, 2026
    Oct 31, 2025-$4.35-$3.28-$3.28 - -$3.28N/AN/AN/A10 up, 0 downDec 11, 2025
    Jul 31, 2025$0.04-$12.11-$12.11 - -$12.11+100.33%BeatN/A11 up, 0 downOct 27, 2025
    Apr 30, 2025-$16.40-$17.60N/A+6.82%Beat-199.4%N/A0 up, 0 downJun 16, 2025
    Jan 31, 2025-$2.33-$1.94N/A-20.10%MissN/AN/A0 up, 0 downMar 12, 2025
    Oct 31, 2024-$33.00-$12.00N/A-175.00%Miss-161.1%N/A0 up, 0 downDec 16, 2024
    Jul 31, 2024-$0.07-$0.46N/A+84.78%BeatN/A10 up, 0 downOct 23, 2024
    Apr 30, 2024$16.50-$82.50N/A+120.00%BeatN/A10 up, 0 downJun 14, 2024
    Jan 31, 2024-$106.50-$30.00N/A-255.00%MissN/A10 up, 0 downMar 18, 2024
    Oct 31, 2023$54.00-$27.00N/A+300.00%BeatN/A10 up, 0 downDec 14, 2023
    Jul 31, 2023-$0.15-$0.39N/A+61.54%BeatN/AN/AN/AOct 25, 2023
    Apr 30, 2023-$48.00-$53.25N/A+9.86%BeatN/AN/AN/AJun 14, 2023
    Jan 31, 2023-$115.50-$53.25N/A-116.90%MissN/AN/A0 up, 0 downMar 15, 2023
    Oct 31, 2022-$10.50-$49.50N/A+78.79%BeatN/AN/A0 up, 0 downDec 14, 2022
    Jul 31, 2022-$1.02-$0.35-$0.35 - -$0.35-191.43%MissN/A10 up, 0 downOct 27, 2022
    Apr 30, 2022-$48.00-$31.50N/A-52.38%Miss-152.7%10 up, 0 downJun 13, 2022
    Jan 31, 2022-$36.00-$24.75N/A-45.45%MissN/A10 up, 0 downMar 15, 2022
    Oct 31, 2021-$0.16N/AN/AN/AN/AN/AN/AN/ADec 14, 2021
    Apr 30, 2021$91.03N/AN/AN/AN/AN/AN/AN/AJun 29, 2021
    Jan 31, 2021-$43.71N/AN/AN/AN/AN/AN/AN/AMar 31, 2021
    Oct 31, 2020-$71.24N/AN/AN/AN/AN/AN/AN/AOct 31, 2020
    Jul 31, 2020-$105.72N/AN/AN/AN/AN/AN/AN/AJul 31, 2020
    Apr 30, 2020-$105.79N/AN/AN/AN/AN/AN/AN/AApr 30, 2020
    Jan 31, 2020-$297.18N/AN/AN/AN/AN/AN/AN/AApr 30, 2020
    Oct 31, 2019-$1.82N/AN/AN/AN/AN/AN/AN/AOct 31, 2019
    Jul 31, 2019-$292.34N/AN/AN/AN/AN/AN/AN/AJul 31, 2019
    Apr 30, 2019-$281.08N/AN/AN/AN/AN/AN/AN/AApr 30, 2019
    Jan 31, 2019-$328.34N/AN/AN/AN/AN/AN/AN/AApr 30, 2019
    Oct 31, 2018-$225.64N/AN/AN/AN/AN/AN/AN/AOct 31, 2018
    Jul 31, 2018-$465.55N/AN/AN/AN/AN/AN/AN/AJul 31, 2018
    Apr 30, 2018-$464.88N/AN/AN/AN/AN/AN/AN/AApr 30, 2018
    Jan 31, 2018-$309.40N/AN/AN/AN/AN/AN/AN/AJan 31, 2018
    Oct 31, 2017-$207.67N/AN/AN/AN/AN/AN/AN/AOct 31, 2017
    Jul 31, 2017-$382.27N/AN/AN/AN/AN/AN/AN/AJul 31, 2017
    Apr 30, 2017-$387.91N/AN/AN/AN/AN/AN/AN/AApr 30, 2017
    Jan 31, 2017-$139.93N/AN/AN/AN/AN/AN/AN/AApr 30, 2017
    Oct 31, 2016-$163.55N/AN/AN/AN/AN/AN/AN/AOct 31, 2016
    Jul 31, 2016-$147.13N/AN/AN/AN/AN/AN/AN/AJul 31, 2016
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Jul 31, 2026 was -$9.16, after -$51.69 the year before. It was -$865.95 for the year ended Jul 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Jul 31, 2026-$9.16N/A
    Jul 31, 2025-$51.69N/A
    Jul 31, 2024-$36.07N/A
    Jul 31, 2023-$174.15N/A
    Jul 31, 2022-$109.10N/A
    Jul 31, 2020-$510.52N/A
    Jul 31, 2019-$1,127.40N/A
    Jul 31, 2018-$1,447.50N/A
    Jul 31, 2017-$1,073.65N/A
    Jul 31, 2016-$865.95N/A

    Frequently Asked Questions About BCTX

    When is Briacell Therapeutics's next earnings date?

    Briacell Therapeutics's next earnings report is expected for Dec 10, 2026.

    How often does BCTX beat earnings estimates?

    Briacell Therapeutics beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate, with an average surprise of +20.23%.